Latest news
AbCellera to Release Phase 2 Top-Line Results for ABCL635 and Host Investor Call Aug 10 - TradingViewTradingView · Fri, 07 Aug 2026 20:53:02 GMTAbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMT